- Home
- ABUS vs ALRS Comparison
ABUS vs ALRS Comparison
Compare ABUS & ALRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABUS
- ALRS
- Stock Information
- Founded
- ABUS N/A
- ALRS 1879
- Country
- ABUS United States
- ALRS United States
- Employees
- ABUS N/A
- ALRS N/A
- Industry
- ABUS Biotechnology: Pharmaceutical Preparations
- ALRS Major Banks
- Sector
- ABUS Health Care
- ALRS Finance
- Exchange
- ABUS Nasdaq
- ALRS Nasdaq
- Market Cap
- ABUS 629.1M
- ALRS 550.5M
- IPO Year
- ABUS N/A
- ALRS 2019
- Fundamental
- Price
- ABUS $3.42
- ALRS $20.63
- Analyst Decision
- ABUS Strong Buy
- ALRS Hold
- Analyst Count
- ABUS 4
- ALRS 5
- Target Price
- ABUS $5.50
- ALRS $23.60
- AVG Volume (30 Days)
- ABUS 646.4K
- ALRS 72.5K
- Earning Date
- ABUS 03-03-2025
- ALRS 01-28-2025
- Dividend Yield
- ABUS N/A
- ALRS 3.88%
- EPS Growth
- ABUS N/A
- ALRS 68.97
- EPS
- ABUS N/A
- ALRS 0.98
- Revenue
- ABUS $6,742,000.00
- ALRS $203,835,000.00
- Revenue This Year
- ABUS N/A
- ALRS N/A
- Revenue Next Year
- ABUS N/A
- ALRS $4.81
- P/E Ratio
- ABUS N/A
- ALRS $21.05
- Revenue Growth
- ABUS N/A
- ALRS 22.78
- 52 Week Low
- ABUS $2.30
- ALRS $17.99
- 52 Week High
- ABUS $4.72
- ALRS $24.41
- Technical
- Relative Strength Index (RSI)
- ABUS 54.07
- ALRS 44.99
- Support Level
- ABUS $3.24
- ALRS $20.95
- Resistance Level
- ABUS $3.44
- ALRS $21.94
- Average True Range (ATR)
- ABUS 0.12
- ALRS 0.65
- MACD
- ABUS 0.01
- ALRS -0.09
- Stochastic Oscillator
- ABUS 55.56
- ALRS 8.67
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.
About ALRS Alerus Financial Corporation
Alerus Financial Corp is a financial holding company registered in the United States. The company operates in four segments: Banking, Retirement & Benefit Services, Wealth Management, and Mortgage. It provides various banking services such as checking, debit cards, savings, current deposits, loans and advances, online banking, mobile banking, private banking, payment solutions, and other business products. Additionally, the company provides mortgage loans, retirement planning solutions, individual retirement accounts, retirement plan advisory services as well as wealth management services, including financial & estate planning, trust, and fiduciary services. The company's revenue mainly consists of interest income, commission, management fees, and other income.